Skip to main content
editorial
. 2018 Oct 29;9(11):1070–1072. doi: 10.1021/acsmedchemlett.8b00456

Figure 1.

Figure 1

Maps of the structure–activity relationship (SAR) data derived from cytotoxicity analyses (tumor cell GI50 values) on synthetic or semisynthetic derived SPLMs displayed with FD-895 (1a), 17S-FD-895 (1b), cyclopropane 1c, spliceostatin A (2), and herboxidiene (3). Chemical modifications either enhance (blue) or attenuate (orange) activity.